TIDMEDEN
Eden Research plc
28 November 2023
Eden Research to Present at the Small Cap Virtual Investor
Conference November 30, 2023
Company invites individual and institutional investors, as well
as advisors and analysts, to attend in person or online at
VirtualInvestorConferences.com
Didcot, Oxfordshire, November 28, 2023 -- Eden Research plc
(AIM:EDEN | OTCQB: EDNSF), based in Oxfordshire, UK, focused on
sustainable biopesticides and plastic-free formulation technology
for use in global crop protection, animal health and consumer
products industries, today announced that Sean Smith, Chief
Executive Officer, will present live at the Small Cap Virtual
Investor Conference, hosted by VirtualInvestorConferences.com, on
November 30, 2023.
DATE : November 30, 2023
TIME: 09:30 - 10:00 ET | 14:30 - 15:00 GMT
LINK: https://bit.ly/46MMy8s
This will be a live, interactive online event where investors
are invited to ask the company
questions in real-time. If attendees are not able to join the
event live on the day of the
conference, an archived webcast will also be made available
after the event.
It is recommended that online investors pre-register and run the
online system check to expedite participation and receive event
updates.
Learn more about the event at www.virtualinvestorconferences.com
.
Recent Company Highlights
-- Launch of Ecovelex, Eden's third flagship sustainable crop
protection product, in collaboration with Corteva
-- Successful fundraise of GBP9.9 (c. $12.5) million to accelerate the company's growth
-- Various regulatory approvals across key regions including the US and Central Europe
-- Recent regulatory approvals have converted to 55% rise in product sales in FY 2022.
-- Over 140 field trials run in 2023 with potential distribution
partners for an insecticide, Eden's next crop protection
product
###
About Eden Research plc
Eden Research is the only UK-listed company focused on
biopesticides for sustainable agriculture. It develops and supplies
innovative biopesticide products and natural microencapsulation
technologies to the global crop protection, animal health and
consumer products industries.
Eden's products are formulated with terpene active ingredients,
based on natural plant defence metabolites. To date, they have been
primarily used on high-value fruits and vegetables, improving crop
yields and marketability, with equal or better performance when
compared with conventional pesticides. Eden has two products
currently on the market:
Based on plant-derived active ingredients, Mevalone(R) is a
foliar biofungicide which initially targets a key disease affecting
grapes and other high-value fruit and vegetable crops. It is a
useful tool in crop defence programmes and is aligned with the
requirements of integrated pest management programmes. It is
approved for sale in a number of key countries whilst Eden and its
partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.
Cedroz(TM) is a bionematicide that targets free living nematodes
which are parasitic worms that affect a wide range of high-value
fruit and vegetable crops globally. Cedroz is registered for sale
on two continents and Eden's commercial collaborator, Eastman
Chemical, is pursuing registration and commercialisation of this
important new product in numerous countries globally.
Eden's Sustaine(R) encapsulation technology is used to harness
the biocidal efficacy of naturally occurring chemicals produced by
plants (terpenes) and can also be used with both natural and
synthetic compounds to enhance their performance and ease-of-use.
Sustaine microcapsules are naturally-derived, plastic-free,
biodegradable micro-spheres derived from yeast. It is one of the
only viable, proven and immediately registerable solutions to the
microplastics problem in formulations requiring encapsulation.
Eden was admitted to trading on AIM on 11 May 2012 and trades
under the symbol EDEN. It was awarded the London Stock Exchange
Green Economy Mark in January 2021, which recognises London-listed
companies that derive over 50% of their total annual revenue from
products and services that contribute to the global green economy.
Eden derives 100% of its total annual revenues from sustainable
products and services.
For more information about Eden, please visit: www.edenresearch.com .
About Virtual Investor Conferences(R)
Virtual Investor Conferences (VIC) is the leading proprietary
investor conference series that provides an interactive forum for
publicly traded companies to seamlessly present directly to
investors.
Providing a real-time investor engagement solution, VIC is
specifically designed to offer companies more efficient investor
access. Replicating the components of an on-site investor
conference, VIC offers companies enhanced capabilities to connect
with investors, schedule targeted one-on-one meetings and enhance
their presentations with dynamic video content. Accelerating the
next level of investor engagement, Virtual Investor Conferences
delivers leading investor communications to a global network of
retail and institutional investors.
CONTACTS:
Hawthorn Advisors (PR advisor to Eden Research)
eden@hawthornadvisors.com
+44 (0)20 3745 4960
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFIFSELDLTFIV
(END) Dow Jones Newswires
November 28, 2023 02:00 ET (07:00 GMT)
Grafico Azioni Eden Research (LSE:EDEN)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Eden Research (LSE:EDEN)
Storico
Da Nov 2023 a Nov 2024
